You just read:

For Moderate to Severe Systemic Lupus Erythematosus, Epratuzumab Has the Potential to Offer Improvements over IV Belimumab in Health-Related Quality of Life and Time to Response

News provided by

Decision Resources Group

Apr 28, 2014, 10:00 ET